4DMedical

4DMedical Enterprise Value

The Enterprise Value (EV) of 4DMedical (4DX.AX) as of Nov 4, 2026 is 1.89 B AUD. In the previous year, Enterprise Value (EV) was 2.16 B AUD — a change of -12.58% (lower).

Enterprise Value

1.89 BAUD

YoY

-12.58%

Last updated:

Enterprise Value (EV) of 4DMedical is 2026 1.89 B AUD. Enterprise Value (EV) of 4DMedical was 2025 2.16 B AUD. It decreases by -12.58% lower compared to the previous year.

The 4DMedical Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
2.17 B AUD
Jan 1, 2020
2.18 B AUD
Jan 1, 2021
2.09 B AUD
Jan 1, 2022
2.12 B AUD
Jan 1, 2023
2.10 B AUD
Jan 1, 2024
2.14 B AUD
Jan 1, 2025
2.16 B AUD
Jan 1, 2026
1.89 B AUD
The 4DMedical Enterprise Value history
YEAREnterprise ValueYoY
1.89 BAUD-12.58%
2.16 BAUD+1.07%
2.14 BAUD+1.85%
2.10 BAUD-0.92%
2.12 BAUD+1.64%
2.09 BAUD-4.03%
2.18 BAUD+0.39%
2.17 BAUD+0.03%
2.17 BAUD+0.02%
2.17 BAUD-0.05%
2.17 BAUD+0.00%
2.17 BAUD0.00%
2.17 BAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

4DMedical Stock analysis

What does 4DMedical do? 4DMedical Ltd. commercializes its XV Technology, a four-dimensional lung imaging platform, through FDA-cleared XV Lung Ventilation Analysis Software (XV LVA) and CT LVAS, delivered via a software-as-a-service model. The company sells these products to hospitals and clinics, including I-MED Radiology Network, which operates approximately 250 clinics nationwide. XV LVAS and CT LVAS reports are generated using the company’s software, leveraging existing hospital imaging equipment or the XV Scanner. The firm’s revenue comes from SaaS subscriptions and software licensing for its imaging solutions. I-MED Radiology Network is a key client, with 4DMedical initiating the commercial rollout of XV LVAS within its network. The company provides lung imaging technology to selected clinics across I-MED, utilizing the XV Scanner or existing hospital equipment. Revenue streams are derived from the SaaS delivery model, with no mention of additional products or services beyond XV LVA and CT LVAS. 4DMedical’s flagship technology powers dynamic lung ventilation analysis, enabling physicians to identify respiratory issues earlier. The company’s products are designed for use with existing hospital imaging systems, reducing the need for additional hardware. The primary buyers are medical imaging providers like I-MED, which integrate XV Technology into their diagnostic services for respiratory conditions. 4DMedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 4DMedical stock

Enterprise Value (EV) of 4DMedical is 1.89 B AUD in 2026.

Enterprise Value (EV) of 4DMedical changed from 2.16 B AUD to 1.89 B AUD, representing a -12.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) 4DMedical since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s AUD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' AUD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s 4DMedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — 4DMedical

All Key Metrics — 4DMedical